Accessibility links
bivalent vaccine bivalent vaccine
Stories About

bivalent vaccine

Monday

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

The new booster shot would be an update to Pfizer's current version of the shot, which was designed for the original strain of the coronavirus. Nam Y. Huh/AP hide caption

toggle caption
Nam Y. Huh/AP

Shots - Health News

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

Thursday

Summer boosters for people under 50 shelved in favor of updated boosters in the fall

The Biden administration plans to offer updated booster shots in the fall. Mario Tama/Getty Images hide caption

toggle caption
Mario Tama/Getty Images

Shots - Health News

Summer boosters for people under 50 shelved in favor of updated boosters in the fall

The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead officials will push for an earlier release of the next generation boosters in the fall.

Summer boosters for people under 50 shelved in favor of updated boosters in the fall

Listen · 3:35
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1114408611/1114417139" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Moderna says its new 'bivalent' vaccine shows promise against COVID variants

A health care worker prepares the current COVID vaccine booster shots from Moderna in February. The company says a bivalent vaccine that combines the original strain with the omicron strain is the lead candidate for a fall vaccination campaign. Bloomberg/Bloomberg via Getty Images hide caption

toggle caption
Bloomberg/Bloomberg via Getty Images

Shots - Health News

Moderna says its new 'bivalent' vaccine shows promise against COVID variants

The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.